Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Joint pain from cancer drug measured in new study

NCT ID NCT03455907

Knowledge-focused Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study looked at how often joint pain occurs in 71 people with ovarian, colorectal, or lung cancer who were taking the drug bevacizumab. Participants filled out a questionnaire about their joint pain over 6 months. The goal was to better understand this side effect.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
bevacizumab
What this could lead to
If successful, this study could help doctors better understand and manage joint pain as a side effect of bevacizumab in cancer patients.
What could go wrong
This is a small, completed observational survey, not a treatment trial. It only measures how often joint pain happens, not whether it can be prevented or cured.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

71 people

The number who actually took part.

Started

Jan 2018

Finished

Jan 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Patients treated with Bevacizumab for Lung, ovarian or colorectal cancers.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Patient with ovarian, colorectal or lung cancer receiving bevacizumab therapy * Male or female (aged ≥18 years old) * Performance Status (PS) between 0 and 2 * Expected life\> 3 months * Ability to answer a self-questionnaire * Obtaining the non-opposition of patient participation Exclusion Criteria: * Pregnant or lactating woman * Rapid evolution of neoplastic pathology * Major cognitive disorders that do not allow filling of the self-questionnaire * Impossibility to submit to medical monitoring for social, psychological or geographical reasons * Patients under guardianship or curatorship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Arthralgia are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Arthralgia colorectal cancer lung cancer ovarian cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Arthralgia

Contacts and locations

Locations

  • Centre Oscar Lambret

    Lille, France

  • Hôpital Huriez. CHRU

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.